The weight of obesity on lung health

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 4, 2013, Pages 403-404

  Dixon, Anne E ^a   Lundblad, Lennart K A ^a   Suratt, Benjamin T ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN;

2009 H1N1 INFLUENZA; ACUTE LUNG INJURY; BACTERIAL PNEUMONIA; BODY WEIGHT; CHOLESTEROL METABOLISM; CHRONIC OBSTRUCTIVE LUNG DISEASE; EDITORIAL; HYPERCHOLESTEROLEMIA; LUNG DISEASE; OBESITY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ADULT; HUMANS; LUNG; LUNG DISEASES; OBESITY; RESPIRATORY PHYSIOLOGICAL PROCESSES; RISK FACTORS; UNITED STATES;

EID: 84880508227     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.03.017     Document Type: Editorial

References (14)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief 2012. U.S. Department of Health and Human Services, Centers for Disease Control, National Center for Health Statistics; vol. 82. p. 1-8.
2. Wang Y.C., McPherson K., Marsh T., Gortmaker S.L., Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011, 378:815-825.
3. Finucane M.M., Stevens G.A., Cowan M.J., Danaei G., Lin J.K., Paciorek C.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
4. Mahadev S, Farah CS, King GG, Salome CM. Obesity, expiratory flow limitation and asthma symptoms. Pulm Pharmacol Ther, in this issue.
5. Vernooy JH, Ubags ND, Brusselle GG, Tavernier J, Suratt BT, Wouters EF, etal. Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases. Pulm Pharmacol Ther, in this issue.
6. Konter J, Baez E, Summer RS. Obesity: "Priming" the lung for injury. Pulm Pharmacol Ther, in this issue.
7. Medoff BD. Fat, fire and muscle - the role of adiponectin in pulmonary vascular inflammation and remodeling. Pulm Pharmacol Ther, in this issue.
8. Gowdy KM, Fessler MB. Emerging roles for cholesterol and lipoproteins in lung disease. Pulm Pharmacol Ther, in this issue.
9. Stapleton R.D., Dixon A.E., Parsons P.E., Ware L.B., Suratt B.T. The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest 2010, 138:568-577.
10. Palvinskaya T, Antkowiak M, Burg E, Lenox CC, Ubags N, Cramer A, etal. Effects of acute and chronic low density lipoprotein exposure on neutrophil function. Pulm Pharmacol Ther, in this issue.
11. Mancuso P. Obesity and respiratory infections: does adiposity weigh down host defense? Pulm Pharmacol Ther, in this issue.
12. Williams AS, Chen L, Kasahara DI, Si H, Wurmbrand AP, Shore SA. Obesity and airway responsiveness: role of TNFR2. Pulm Pharmacol Ther, in this issue.
13. Sideleva O, Black K, Dixon AE. Effects of obesity and weight loss on airway physiology and inflammation in asthma. Pulm Pharmacol Ther, in this issue.
14. Stevenson C, Yew-Booth L. Is intrinsic aerobic exercise capacity a determinant of COPD susceptibility? Pulm Pharmacol Ther, in this issue.